Hospitals | February 18, 2026
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
Growing patent filings and tier-2 innovators reflect expanding national research base
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
In the next five years, an additional 75,000 seats are expected to be added across both undergraduate and postgraduate levels
Several technologies for hemoglobinopathies are being transferred to commercial partners
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
Subscribe To Our Newsletter & Stay Updated
